montreal-cognitive-assessment

title: Montreal Cognitive Assessment (MoCA)
description: Page for Montreal Cognitive Assessment (MoCA)
published: true
tags: kind:diagnostic, section:diagnostics, state:published
editor: markdown
pageId: 1823
dateCreated: "2026-03-01T06:38:02.918Z"
dateUpdated: "2026-03-24T04:05:33.679Z"

Montreal Cognitive Assessment (MoCA)

Introduction

Montreal Cognitive Assessment (Moca) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

The Montreal Cognitive Assessment (MoCA) is a widely used cognitive screening instrument designed to detect mild cognitive impairment (MCI). Developed in 2005 by Ziad Nasreddine and colleagues at the Memory Clinic of the McGill University Health Centre in Montreal, Canada, the MoCA has become one of the most frequently used cognitive screening tools in clinical and research settings[@ref].

Overview

...

title: Montreal Cognitive Assessment (MoCA)
description: Page for Montreal Cognitive Assessment (MoCA)
published: true
tags: kind:diagnostic, section:diagnostics, state:published
editor: markdown
pageId: 1823
dateCreated: "2026-03-01T06:38:02.918Z"
dateUpdated: "2026-03-24T04:05:33.679Z"

Montreal Cognitive Assessment (MoCA)

Introduction

Montreal Cognitive Assessment (Moca) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

The Montreal Cognitive Assessment (MoCA) is a widely used cognitive screening instrument designed to detect mild cognitive impairment (MCI). Developed in 2005 by Ziad Nasreddine and colleagues at the Memory Clinic of the McGill University Health Centre in Montreal, Canada, the MoCA has become one of the most frequently used cognitive screening tools in clinical and research settings[@ref].

Overview

The MoCA is a brief, 10-minute test that assesses multiple cognitive domains. It was specifically designed to be more sensitive than the Mini-Mental State Examination (MMSE) for detecting milder forms of cognitive impairment, particularly in the early stages of neurodegenerative diseases["^2"]. The test has been validated in hundreds of peer-reviewed studies and is available in over 50 languages and dialects["^3"].

Cognitive Domains Tested

The MoCA assesses six major cognitive domains[@ref]:

Executive Function: Trail-making, verbal fluency, and abstract reasoning tasks

Visuospatial Skills: Cube copying and clock drawing tests

Attention: Digit span, vigilance, and serial sevens

Memory: Delayed word recall with learning trials

Language: Object naming, sentence repetition, and verbal fluency

Orientation: Time and place orientation

1. Short-Term Memory

The test includes delayed recall of a five-word list, evaluating verbal memory function. This component is particularly sensitive to early memory deficits seen in Alzheimer's Disease[^2] and other dementias[@ref].

2. Visuospatial Abilities

Participants are asked to copy a cube and draw a clock face with a specific time. These tasks assess visuoconstructional skills and spatial planning abilities that are often affected in Frontotemporal Dementia and Posterior Cortical Atrophy[^2].

3. Executive Functions

Executive function is assessed through a trail-making task (alternating between numbers and letters), phonemic fluency, and the clock-drawing task. These functions are particularly vulnerable in Parkinson's Disease, Huntington's Disease, and vascular cognitive impairment[^3].

4. Attention, Concentration, and Working Memory

Simple attention is tested through a digit span task (forward and backward), while sustained attention is assessed via a continuous subtraction task. Working memory is evaluated through the digit span backward component[@ref].

5. Language

Language assessment includes object naming, sentence repetition, and phonemic fluency (generating words beginning with a specific letter). Language deficits are prominent in Primary Progressive Aphasia and Alzheimer's Disease[^2].

6. Orientation to Time and Place

Participants are asked to state the current date, day of week, and location (city, hospital/clinic). Disorientation is a hallmark of advanced dementia but can appear early in certain conditions[@ref].

Scoring

The MoCA is scored out of 30 points, with different cognitive domains contributing varying numbers of points:

| Domain | Maximum Points |
|--------|---------------|
| Visuospatial/Executive | 5 |
| Naming | 3 |
| Attention | 6 |
| Language | 3 |
| Abstraction | 2 |
| Delayed Recall | 5 |
| Orientation | 6 |

A score of 26 or above is generally considered within the normal range, though the cutoff may vary based on education level and demographic factors[^3]. However, some studies suggest that age and education-adjusted cutoffs may be more appropriate for specific populations[^4].

Clinical Applications in Neurodegenerative Diseases

The MoCA is used to detect and monitor cognitive impairment in numerous neurodegenerative conditions[^2]:

• /diseases/alzheimers|Alzheimer's Disease: Sensitive to early memory deficits; scores typically decline 2-4 points annually in moderate stages[^3]
• /diseases/parkinsons-disease|Parkinson's Disease: Useful for detecting mild cognitive impairment (MCI-PD); MoCA cutoffs of <26 identify cognitive impairment with high sensitivity
• /diseases/mild-cognitive-impairment|Mild Cognitive Impairment: Primary screening tool for amnestic MCI; detects conversion risk to /diseases/alzheimers|Alzheimer's Disease[^4]
• /diseases/vascular-cognitive-impairment|Vascular Cognitive Impairment: Captures executive dysfunction typical of subcortical vascular damage
• /diseases/frontotemporal-dementia|Frontotemporal Dementia: Reveals frontal/executive patterns even with relatively preserved memory
• /diseases/dementia-with-lewy-bodies|Lewy Body Dementia: Sensitive to attention and visuospatial deficits characteristic of DLB[^5]

Alzheimer's Disease (AD)

The MoCA is highly sensitive (90%) for detecting mild cognitive impairment due to Alzheimer's Disease, significantly outperforming the MMSE (18% sensitivity) in this regard[^3]. It is commonly used in memory clinics and research trials for early detection.

Parkinson's Disease (PD)

In Parkinson's Disease, the MoCA is used to detect Parkinson's Disease Mild Cognitive Impairment (PD-MCI), which affects up to 50% of PD patients. Specific subtests, particularly executive function and attention tasks, are particularly sensitive to PD-related cognitive changes[^2].

Lewy Body Dementia (LBD)

The MoCA can help distinguish Lewy Body Dementia from Alzheimer's Disease, as patients with LBD often show particular deficits in attention and executive functions. Fluctuations in cognition, a core feature of LBD, can also be assessed through repeated administrations[^3].

Frontotemporal Dementia (FTD)

Patients with FTD often show characteristic patterns of impairment on the MoCA, with particular deficits in executive function and language tasks. The test helps differentiate FTD from Alzheimer's Disease, which typically shows more prominent memory impairment[^2].

Huntington's Disease

Cognitive decline is a core feature of Huntington's Disease, and the MoCA is used to track disease progression. Executive dysfunction and attention deficits are typically the earliest cognitive changes detected[^3].

Vascular Cognitive Impairment (VCI)

The MoCA is sensitive to the cognitive deficits associated with cerebrovascular disease, including multi-infarct dementia and subcortical Vascular Dementia. Executive function and attention tasks are particularly affected in VCI[^4].

Amyotrophic Lateral Sclerosis (ALS)

Cognitive impairment, including frontotemporal dysfunction, occurs in up to 50% of ALS patients. The MoCA provides a brief screening tool to detect these deficits, though more comprehensive neuropsychological testing is often warranted[^3].

Advantages Over MMSE

The MoCA offers several advantages over the older MMSE:

Higher Sensitivity: The MoCA detects 90% of MCI cases compared to only 18% for MMSE[^3]

Broader Domain Coverage: Includes more extensive testing of executive functions

Shorter Administration: Takes approximately 10 minutes vs. 15-20 minutes for MMSE

More Cultural Adaptations: Available in 50+ language versions

Free for Clinical Use: The paper version is freely available

Limitations

Despite its widespread use, the MoCA has limitations:

• Education Bias: Performance is affected by years of education; cutoffs may need adjustment
• Ceiling Effects: Less sensitive to severe cognitive impairment
• Language/Cultural Factors: Some items may not translate well across cultures
• Floor Effects: May not be suitable for patients with severe dementia
• Limited Diagnostic Specificity: A low score indicates cognitive impairment but does not specify the etiology

Available Versions

Multiple versions of the MoCA have been developed to address various clinical needs[^3]:

Standard MoCA: The original version for in-person administration

MoCA Blind: For patients who cannot see

MoCA Hearing: For patients with hearing impairment

MoCA Education: Modified for patients with lower educational attainment

Telephone MoCA (T-MoCA): For remote administration

MoCA for Virtual Reality: Digital administration platform

External Links

• [MoCA Cognition Official Website](https://mocacognition.com/)
• [MoCA Test Download](https://mocacognition.com/paper-version/)
• [MoCA Validation Studies](https://pubmed.ncbi.nlm.nih.gov/?term=Montreal+Cognitive+Assessment)

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [ALS](/diseases/amyotrophic-lateral-sclerosis)
• [Huntington's Disease](/diseases/huntingtons)
• [Frontotemporal Dementia](/diseases/frontotemporal-dementia)
• [Lewy Body Dementia](/diseases/lewy-body-dementia)
• [Vascular Dementia](/diseases/vascular-dementia)
• [Diagnostics Index](/diagnostics)

Background

The study of Montreal Cognitive Assessment (Moca) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Research Evidence

Dynamic functional connectivity measures are more reliable than stationary connectivity measures in attention networks

[Madhyastha et al., (2015)](https://doi.org/10.1089/brain.2014.0248)

Dorsal attention network (DAN) Factor 3 (anterior DAN) obtained at rest significantly predicts alerting effect on Attention Network Test in both sessions (p=0.001 and p=0.037)

[Madhyastha et al., (2015)](https://doi.org/10.1089/brain.2014.0248)

Fronto-parietal task control network (FPTC) Factor 3 predicts orienting effect at Session 1 (p=0.010)

[Madhyastha et al., (2015)](https://doi.org/10.1089/brain.2014.0248)

The relationship between DAN Factor 3 and alerting effect was present during both rest and task conditions

[Madhyastha et al., (2015)](https://doi.org/10.1089/brain.2014.0248)

Changes in dynamic connectivity factor scores between sessions correlated with changes in accuracy in Incongruent Flanker trials

[Madhyastha et al., (2015)](https://doi.org/10.1089/brain.2014.0248)

Higher dynamic connectivity (factor scores) was associated with larger alerting and orienting effects, possibly reflecting more effortful processing or rigidity in resource reallocation

[Madhyastha et al., (2015)](https://doi.org/10.1089/brain.2014.0248)

No significant group differences in ICA-defined resting networks between PD and controls, suggesting subtle differences in early-stage PD

[Madhyastha et al., (2015)](https://doi.org/10.1089/brain.2014.0248)

Dynamic connectivity factor structures are stable across rest and task states (Procrustes congruence 0.89-0.93 for DAN)

[Madhyastha et al., (2015)](https://doi.org/10.1089/brain.2014.0248)

Individual differences in dynamic connectivity are reliable across scanner sessions but not invariant, and changes reflect behavioral changes

[Madhyastha et al., (2015)](https://doi.org/10.1089/brain.2014.0248)

Attention Network Test (ANT) behavioral performance measurement

PD participants showed slowed response latencies across all conditions. PD participants had significantly larger alerting effect (No Cue - Center Cue) compared to controls (PD: 47ms vs Controls: 28ms, p=0.025). No significant differences in orienting or executive effects between groups.

Model System: Human participants: 25 Parkinson disease (PD) patients and 21 healthy controls (ages 41-86)

Statistical Significance: p = 0.025 for alerting effect difference between groups

[Madhyastha et al., (2015)](https://doi.org/10.1089/brain.2014.0248)

ICA analysis of resting-state networks

Identified dorsal attention network (DAN), salience network, and default mode network (DMN). No significant group differences found between PD and controls in these networks.

Model System: Human participants: 25 PD patients and 21 controls undergoing resting-state fMRI

Statistical Significance: No significant group differences (p > 0.05 after correction)

[Madhyastha et al., (2015)](https://doi.org/10.1089/brain.2014.0248)

Dynamic connectivity factor analysis

Extracted 4 factors for each network (DAN, FPTC, DMN). Factor structures were qualitatively similar to previous aging sample but explained less variance in this sample. Reliability of factor scores was higher than reliability of individual pairwise correlations.

Model System: Human participants: 25 PD and 21 controls during resting-state fMRI scans

Statistical Significance: DAN factor reliability 0.56-0.64, FPTC 0.35-0.69, DMN 0.57-0.78 (all p < 0.01 except FPTC Factor 4 p=0.01)

[Madhyastha et al., (2015)](https://doi.org/10.1089/brain.2014.0248)

Reliability comparison: dynamic vs stationary connectivity

Dynamic connectivity measures are more reliable than stationary connectivity measures. Median reliability of factor scores higher than median reliability of pairwise correlations for DAN (p=0.020) and DMN (p=0.036). FPTC showed marginally significant difference (p=0.082).

Model System: Same 46 participants in resting-state fMRI

Statistical Significance: DAN: p=0.020, DMN: p=0.036, FPTC: p=0.082

[Madhyastha et al., (2015)](https://doi.org/10.1089/brain.2014.0248)

Prediction of alerting effect from resting-state dynamic connectivity

DAN Factor 3 (anterior DAN) significantly predicted alerting effect magnitude at both sessions (Session 1: p=0.001, R2=0.21; Session 2: p=0.037, R2=0.09). Effect remained significant after controlling for age. Group-by-factor interaction significant at Session 1 (p=0.002) but not Session 2.

Model System: 46 participants (25 PD, 21 controls) from resting-state scans to ANT performance

Statistical Significance: Session 1: t(44)=3.46, p=0.001; Session 2: t(44)=2.15, p=0.037; Group x Factor interaction Session 1: p=0.002

[Madhyastha et al., (2015)](https://doi.org/10.1089/brain.2014.0248)

Prediction of orienting effect from resting-state dynamic connectivity

FPTC Factor 3 predicted orienting effect at Session 1 (p=0.010) but not Session 2 (p=0.116). No significant group or group-by-factor interaction.

Model System: 46 participants from resting-state scans to ANT orienting effect

Statistical Significance: Session 1: t(44)=2.70, p=0.010; Session 2: t(44)=1.6, p=0.116

[Madhyastha et al., (2015)](https://doi.org/10.1089/brain.2014.0248)

Task-based dynamic connectivity analysis

DAN factor structure during task highly congruent with rest (Procrustes correlation 0.93 Session 1, 0.89 Session 2, p=0.001). DAN Factor 3 during tasks predicted alerting effect (Session 1: p=0.023, R2=0.11; Session 2: p=0.107). During tasks, DAN Factor 3 also negatively predicted orienting effect at Session 2 (p=0.013).

Model System: 46 participants during ANT task fMRI runs

Statistical Significance: DAN Factor 3: Session 1 p=0.023, Session 2 p=0.107; Orienting: Session 2 p=0.013

[Madhyastha et al., (2015)](https://doi.org/10.1089/brain.2014.0248)

Change in dynamic connectivity predicting behavioral change

Increase in DAN Factor 3 between sessions correlated with improvement in accuracy in Incongruent Flanker condition (r=0.37, p=0.011). Increase in FPTC Factor 3 correlated with improvement in Incongruent (r=0.39, p=0.007) and Center Cue conditions (r=0.32, p=0.027).

Model System: Longitudinal: Session 1 to Session 2 change in same 46 participants

Statistical Significance: DAN Factor 3: r(44)=0.37, p=0.011; FPTC Factor 3 Incongruent: r(44)=0.39, p=0.007; FPTC Factor 3 Center Cue: r(44)=0.32, p=0.027

[Madhyastha et al., (2015)](https://doi.org/10.1089/brain.2014.0248)

MoCA Assessme```merflowchart A["Montreal Cognitive Assessment"] --> B["Visuospatial"]

A A --> D["Memory"]
A --> E["Attention"]
A --> F["Language"]
A --> G["Orientation"]

B --> B1 [Cube Copy]
B --> B2 [Clock Drawing]

C --> C1 [Trails Making]
C --> C2 [Verbal Fluency]
C --> C3 [Similarities]

D --> D1 [Word Recall]

E --> E1 [Digits]
E --> E2 [Serial 7s]
E --> E3 [Attention Task]

F --> F1 [Naming]
F --> F2 [Repetition]
F --> F3 [Sentence]

G --> G1 [Date/Time]
G --> G2 [Place]

style A fill:#e1f5fe
style B fill:#fff3e0
style C fill:#e8f5e9
style D fill:#fce4ec
style E fill:#f3e5f5
style F fill:#ffecb3
style G fill:#b2dfdb
```